|
Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy
|
November 6, 2025
|
PC3I Authors Aditi Singh; Christopher A. D’Avella; Melina Marmarelis; Charu Aggarwal |
American Journal of Clinical Oncology
|
|
Durvalumab Alone or Combined With Novel Agents for Unresectable Stage III Non-Small Cell Lung Cancer: Update From the COAST Randomized Clinical Trial
|
July 15, 2025
|
PC3I Authors Charu Aggarwal |
JAMA Network Open
|
|
Perioperative Therapy in Oncogene-Driven Non-Small Cell Lung Cancer: Current Strategies and Unanswered Questions
|
June 1, 2025
|
PC3I Authors Charu Aggarwal; Teja Voruganti |
ASCO Educational Book
|
|
Management of Patients With EGFR Exon 20-Mutant Advanced Non-Small Cell Lung Cancer
|
March 7, 2025
|
PC3I Authors Melina Marmarelis; Charu Aggarwal |
Journal of Clinical Oncology
|
|
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
|
February 27, 2025
|
PC3I Authors Charu Aggarwal; Melina Marmarelis |
Nature
|
|
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking
|
February 9, 2025
|
PC3I Authors Charu Aggarwal |
Lung Cancer
|
|
A novel machine learning-based cancer-specific cardiovascular disease risk score among patients with breast, colorectal, or lung cancer
|
January 30, 2025
|
PC3I Authors Charu Aggarwal |
JNCI Cancer Spectrum
|
|
Precision Oncology: A Global Perspective on Implementation and Policy Development
|
January 23, 2025
|
PC3I Authors Charu Aggarwal; Surbhi Grover |
JCO Global Oncology
|
|
Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial
|
July 3, 2024
|
PC3I Authors Melina Marmarelis; Peter Gabriel; Anthony Martella; David Dougherty; Larry Shulman; Justin Bekelman; Charu Aggarwal |
JCO Oncology Practice
|
|
University of Pennsylvania Telehealth Research Center of Excellence
|
June 26, 2024
|
PC3I Authors Jocelyn Wainwright; Charu Aggarwal; David Dougherty; Peter Gabriel; Jillian Kalman; Anthony Martella; Shivan Mehta; Larry Shulman; Jennifer Steltz; Hannah Toneff; Katharine Rendle; Justin Bekelman; Anil Vachani |
Journal of the National Cancer Institute. Monographs
|
|
iNUDGE: Integration of liquid biopsy based next generation gene sequencing in newly diagnosed NSCLC—A stepped wedge cluster randomized clinical trial.
|
May 29, 2024
|
PC3I Authors Anthony Martella; Meagan Hume; Charu Aggarwal; Christopher A. D’Avella; Ramy Sedhom; Peter Gabriel; Katharine Rendle; Justin Bekelman; Melina Marmarelis |
Journal of Clinical Oncology
|
|
Brief Report: Impact of Reflex Testing on Tissue-Based Molecular Genotyping in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
|
April 6, 2024
|
PC3I Authors Melina Marmarelis; Peter Gabriel; Charu Aggarwal |
Clinical Lung Cancer
|
|
Outcomes in patients treated with frontline immune checkpoint inhibition (ICI) for advanced NSCLC with KRAS mutations and STK11/KEAP1 comutations across PD-L1 levels
|
March 3, 2024
|
PC3I Authors Charu Aggarwal |
Lung Cancer (Amsterdam, Netherlands)
|
|
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era
|
January 31, 2024
|
PC3I Authors Charu Aggarwal |
Cancer
|
|
Concurrent Circulating Tumor DNA and Tissue Genotyping-Ready for Prime Time?
|
January 22, 2024
|
PC3I Authors Charu Aggarwal |
JAMA Network Open
|
|
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC
|
November 26, 2023
|
PC3I Authors Charu Aggarwal |
Radiotherapy and Oncology
|
|
Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors
|
October 22, 2023
|
PC3I Authors Charu Aggarwal; Melina Marmarelis |
International Journal of Radiation Oncology, Biology, Physics
|
|
Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression
|
October 9, 2023
|
PC3I Authors Charu Aggarwal; Melina Marmarelis; Christopher A. D’Avella |
Clinical Lung Cancer
|
|
Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumors
|
October 3, 2023
|
PC3I Authors Charu Aggarwal |
British Journal of Cancer
|
|
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
|
August 31, 2023
|
PC3I Authors Catherine Lai; Charu Aggarwal; Melina Marmarelis |
International Journal of Radiation Oncology, Biology, Physics
|
